# Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223

> **NCT02383576** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 185 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02383576
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-30
- **Primary completion:** 2016-01-22
- **Final completion:** 2016-01-22
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2018-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02383576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02383576, "Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02383576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*